Lexicon Pharmaceuticals Inc (LXRX) — Financial Flexibility Index
Lexicon Pharmaceuticals Inc (LXRX) has a Financial Flexibility Index of -0.22x as of March 2026. Free cash flow of $-14.73 Million (operating CF $-14.73 Million minus capex $0.00) represents 0% of total liabilities ($65.96 Million). Also explore Lexicon Pharmaceuticals Inc equity growth rate to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Lexicon Pharmaceuticals Inc Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Lexicon Pharmaceuticals Inc across 27 annual periods. Check asset allocation strategy of Lexicon Pharmaceuticals Inc to assess the company's strategic physical and investment asset allocation.
Annual Financial Flexibility Index for Lexicon Pharmaceuticals Inc (1999–2025)
Year-by-year free cash flow to debt coverage for Lexicon Pharmaceuticals Inc. For the full company profile including market capitalisation, see Lexicon Pharmaceuticals Inc market cap and net worth.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.88x | $-67.85 Million | $-67.85 Million | $77.45 Million | ▲ +24.9% |
| 2024 | -1.17x | $-177.75 Million | $-178.78 Million | $152.47 Million | ▲ +1.6% |
| 2023 | -1.18x | $-161.43 Million | $-161.90 Million | $136.32 Million | ▼ -4.4% |
| 2022 | -1.13x | $-87.53 Million | $-88.85 Million | $77.17 Million | ▲ +69.2% |
| 2021 | -3.68x | $-85.80 Million | $-87.02 Million | $23.31 Million | ▼ -22.1% |
| 2020 | -3.01x | $-142.88 Million | $-142.97 Million | $47.42 Million | ▼ -895.5% |
| 2019 | 0.38x | $113.88 Million | $113.81 Million | $300.61 Million | ▲ +179.2% |
| 2018 | -0.48x | $-148.51 Million | $-148.61 Million | $310.54 Million | ▲ +0.7% |
| 2017 | -0.48x | $-185.17 Million | $-185.39 Million | $384.44 Million | ▲ +12.6% |
| 2016 | -0.55x | $-175.40 Million | $-175.63 Million | $318.22 Million | ▼ -209.5% |
| 2015 | 0.50x | $185.69 Million | $184.78 Million | $368.98 Million | ▲ +224.8% |
| 2014 | -0.40x | $-75.54 Million | $-75.62 Million | $187.36 Million | ▲ +53.1% |
| 2013 | -0.86x | $-89.36 Million | $-91.08 Million | $104.00 Million | ▲ +3.9% |
| 2012 | -0.89x | $-93.97 Million | $-94.46 Million | $105.10 Million | ▼ -37.0% |
| 2011 | -0.65x | $-86.73 Million | $-87.94 Million | $132.94 Million | ▲ +3.7% |
| 2010 | -0.68x | $-81.24 Million | $-82.37 Million | $119.86 Million | ▲ +27.9% |
| 2009 | -0.94x | $-88.65 Million | $-89.02 Million | $94.26 Million | ▲ +33.9% |
| 2008 | -1.42x | $-93.41 Million | $-95.60 Million | $65.68 Million | ▼ -62.5% |
| 2007 | -0.88x | $-72.42 Million | $-74.32 Million | $82.72 Million | ▼ -72.0% |
| 2006 | -0.51x | $-53.33 Million | $-56.91 Million | $104.77 Million | ▼ -294.9% |
| 2005 | 0.26x | $34.72 Million | $23.44 Million | $132.91 Million | ▲ +177.6% |
| 2004 | -0.34x | $-30.45 Million | $-42.26 Million | $90.39 Million | ▼ -1274.2% |
| 2003 | -0.02x | $-2.89 Million | $-7.72 Million | $117.98 Million | ▲ +91.3% |
| 2002 | -0.28x | $-9.03 Million | $-28.79 Million | $31.87 Million | ▼ -35.5% |
| 2001 | -0.21x | $-4.52 Million | $-17.99 Million | $21.62 Million | ▼ -144.0% |
| 2000 | 0.48x | $6.21 Million | $-1.50 Million | $13.06 Million | ▲ +221.8% |
| 1999 | -0.39x | $-5.50 Million | $-9.60 Million | $14.10 Million | — |